Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

GD-23 reduces anxiety by relying on neurosteroid production.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Prophylactic pilocarpine may not prevent angle closure in the other eye.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Pilose antler extract helps hair grow in mice with a type of hair loss by speeding up the growth phase.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Letrozole may help prevent seizures by reducing certain hormone levels.